We are live on
!
Find out more
Ligand Pharmaceuticals
LGND
LGND
212 hedge funds and large institutions have $2.08B invested in Ligand Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 71 increasing their positions, 77 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $2.35B → $2.08B (-$263M)
46% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 35
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
212
Holding in Top 10
2
Calls
$33.4M
Puts
$13.3M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$24.9M | |
| 3 | +$14.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.2M |
| 5 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$7.65M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$10.9M | |
| 3 | -$9.14M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$8.08M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$7.34M |